Diabetes Biomarkers

A gene, molecule, or innate characteristic that aids in diagnosing disease is known as a molecular biomarker. HbA1c is regarded as a biomarker for diabetes that can be used to detect retinopathy, vascular disease, and nephropathy risk factors. These serve as prophylactic actions while the condition is subclinical. A quicker and more thorough understanding of the pathological process of diabetes can be achieved with the right use of the biomarker in the development of anti-diabetic medications.

  • Molecular biomarker
  • Retinopathy
  • Nephropathy risk factors

 

  • Molecular biomarker
  • Retinopathy
  • Nephropathy risk factors

Related Conference of Diabetes Biomarkers

June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
July 20-21, 2026

6th World Congress on Endocrine and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
August 20-21, 2026

6th Annual Summit on Diabetes and Endocrinology

Paris, France
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France
October 20-21, 2026

32nd World Diabetes & Heart Congress

Amsterdam, Netherlands
March 29-30, 2027

8th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands

Diabetes Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in